Table 2.
Chronic effects of LD and HD-PAN on plasma citrulline (Cit), L-Arg, ADMA, L-Arg:ADMA ratio, symmetric (S)DMA, and urinary NOx (stable oxidation products of nitric oxide) excretion rate (UNOXV) in control, LD- and HD-PAN groups
| Control | LD-PAN | HD-PAN | |
|---|---|---|---|
| Cit, μmol/l | 89 ± 10 | 138 ± 15 | 160 ± 23∗ |
| l-Arg, μmol/l | 97 ± 9 | 104 ± 8 | 98 ± 10 |
| ADMA, μmol/l | 0.34 ± 0.01 | 0.50 ± 0.02∗ | 0.74 ± 0.12∗,∗∗ |
| l-ArgADMA | 283 ± 24 | 248 ± 15 | 159 ± 30∗,∗∗ |
| SDMA, μmol/l | 0.29 ± 0.03 | 0.36 ± 0.04 | 0.92 ± 0.18∗,∗∗ |
| UNOXV, μmol/day/100 gBW | 0.56 ± 0.06 | 0.08 ± 0.04∗ | 0.09 ± 0.05∗ |
∗
p < 0.05 vs. control
∗∗
p < 0.05 vs. LD-PAN.